AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.
AEON Biopharma was founded in 2013 by Robert Edward Grant.
1282 health care and life sciences companies are in the directory, 186 of them in the same 1-10 employee range and 48 based in Greater Los Angeles Area.
AEON Biopharma may be growing as evidenced by the completion of a business combination with Priveterra Acquisition Corp., which is typically a strategic move to enhance financial and operational capabilities. Additionally, the company is mentioned in the context of the migraine pipeline and clinical trials in 2023, indicating ongoing research and development activities. Furthermore, AEON Biopharma's partnership with a U.S. company for therapeutic indications suggests expansion in its collaborative efforts to advance its treatment paradigms.
“AEON is developing ABP-450, a proprietary botulinum toxin, to unlock the promise of therapeutic botulinum toxin to treat nervous system-related conditions” aeonbiopharma.com
AEON Biopharma is a biotechnology company based in Greater Los Angeles Area, with 1-10 employees, founded in 2013. Its founder is Robert Edward Grant and it has raised $45 million over 2 rounds.
11-50 employees · adarx.com
101-250 employees · aveooncology.com
11-50 employees · abferopharmaceuticals.com
11-50 employees · artbio.com
51-100 employees · aoporphan.com
1-10 employees · activelifescientific.com
1-10 employees · acesisbio.com
1-10 employees · adaptamedical.com
1-10 employees · aionlabs.com
1-10 employees · 101therapeutics.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.